Skip to main content Skip to main navigation menu Skip to site footer

Vol. 7 No. 1 (2020)

Published: 2019-12-28

Review Articles

Current advances in drug delivery systems for treatment of Triple negative breast cancer (TNBC)

Pooja Mittal, Sujata Singh, Archana Singh, Indrakant K. Singh

1-12
- Requires Subscription or Fee PDF (USD 42)
Contemporary advances in therapeutic portfolio of 2-Azetidinones

Rajneesh Kaur, Dr. (Mrs.) Raman Singh, Priyanka Ahlawat, Parul Kaushik, Kuldeep Singh

13-26
- Requires Subscription or Fee PDF (USD 42)
Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics A review on Corona Virus Disease COVID-19, epidemiology, prevention, and anticipated therapeutic advances

Bhupender S. Chhikara, Brijesh Rathi, Jyoti Singh, Poonam FNU

63-72
- PDF

Research Articles

Design, synthesis and evaluation of 4H-Chromene-4-one analogues as potential Anti-bacterial and Anti-fungal agents

Nidhi Singh, Shridhar Satpute, Naveen Polkam, Ravi Kant, Jaya Shree Anireddy, Deepa Panhekar, Jaya Pandey

27-40
- Requires Subscription or Fee PDF (USD 42)
Antiproliferative actions of Ziziphus jujube fruit extract is mediated through alterations in Bcl2-Bax ratio and through the activation of caspases Anti cancer mechanism of Ziziphus jujube Ber extract

Radhakrishna G Pillai

41-46
- Requires Subscription or Fee PDF (USD 42)
In-silico interactions of active Phytochemicals with c-MYC EGFR and ERBB2 oncoproteins

Vaishali Chandel, Mitul Srivastava, Ashutosh Srivastava, Shailendra Asthana, Dhruv Kumar

47-54
- Requires Subscription or Fee PDF (USD 42)
Anti-microbial and anti-tumor studies of newly synthesized 2-(4-morpholinyl)-4,6-diarylpyrimidines using nanosized NiO catalytic framework

Priyanka Khyaliya, Ahanthem Priyanca Devi, Sudesh Kumar, Ravi Kant, Keshav Lalit Ameta

55-62
- Requires Subscription or Fee PDF (USD 42)